Consolidated Statement of Operations - USD ($)	12 Months Ended
	Oct. 31, 2018	Oct. 31, 2017
Details
Revenues	$ 14,817,799	$ 13,871,495
Cost of expenses:
Cost of revenues	10,481,134	6,449,931
Research and development expenses	593,708	783,014
Selling, general, and administrative expenses	8,887,985	8,021,182
Operating Expenses	19,962,827	15,254,127
Loss from operations	(5,145,028)	(1,382,632)
Interest expense - related party	335,948	170,917
Other Loss	(1,224)	5,221
Loss before income taxes	(5,479,752)	(1,558,770)
Provision for income taxes	4,634	1,961,506
Net loss	$ (5,484,386)	$ (3,520,276)
Net loss per common share - basic	$ (0.71)	$ (0.46)
Net loss per common share - diluted	$ (0.71)	$ (0.46)
Weighted average number of common shares outstanding - basic	7,696,091	7,693,831
Weighted average number of common shares outstanding - diluted	7,696,091	7,693,831